🇺🇸 FDA
Patent

US 9050299

Administration of growth factors for the treatment of CNS disorders

granted A61KA61K33/242A61K33/244

Quick answer

US patent 9050299 (Administration of growth factors for the treatment of CNS disorders) held by The Regents of the University of California expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K33/242, A61K33/244, A61K38/18, A61K38/185